Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3

Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was perfor...

Full description

Saved in:
Bibliographic Details
Published inMediators of inflammation Vol. 2022; pp. 1 - 20
Main Authors Luo, Xiaohua, Pan, Ci, Guo, Xiaopei, Gu, Cunhua, Huang, Yulian, Guo, Jing, Zeng, Ying, Yue, Jinjing, Cui, Shihong
Format Journal Article
LanguageEnglish
Published United States Hindawi 26.05.2022
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.
AbstractList Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.
Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.
Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.
Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.
Audience Academic
Author Huang, Yulian
Gu, Cunhua
Luo, Xiaohua
Guo, Xiaopei
Zeng, Ying
Cui, Shihong
Pan, Ci
Guo, Jing
Yue, Jinjing
AuthorAffiliation 2 Henan Provincial Clinical Research Center for Perinatal Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China
1 Department of Obstetrics and Gynaecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China
AuthorAffiliation_xml – name: 1 Department of Obstetrics and Gynaecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China
– name: 2 Henan Provincial Clinical Research Center for Perinatal Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China
Author_xml – sequence: 1
  givenname: Xiaohua
  surname: Luo
  fullname: Luo, Xiaohua
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 2
  givenname: Ci
  surname: Pan
  fullname: Pan, Ci
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 3
  givenname: Xiaopei
  surname: Guo
  fullname: Guo, Xiaopei
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 4
  givenname: Cunhua
  surname: Gu
  fullname: Gu, Cunhua
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 5
  givenname: Yulian
  surname: Huang
  fullname: Huang, Yulian
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 6
  givenname: Jing
  surname: Guo
  fullname: Guo, Jing
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 7
  givenname: Ying
  surname: Zeng
  fullname: Zeng, Ying
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 8
  givenname: Jinjing
  surname: Yue
  fullname: Yue, Jinjing
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
– sequence: 9
  givenname: Shihong
  orcidid: 0000-0003-2971-558X
  surname: Cui
  fullname: Cui, Shihong
  organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35664920$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1v0zAYhyM0xLrBjTOyxAUJsvkjdpLLpGkwqLSpiA3EzXKcN62rxA52WlSJPx5n7YBOgHyIHT_vY7_J7yg5sM5Ckjwn-IQQzk8ppvQ0oxwLSh4lE5IJkZJCkINkgktB05JxcpgchbDEGPMsK54kh4wLkZUUT5If1zAsNq0ajLPoGmqjBqjRjWnBamPnyDWoM5_SeBC6WfW9hxAgoGEB6C2soXV9B3YYqY8eQLeq64NRaGrRFzN4h5Stt4u1Q9UG3So_h2H0Xs6-ztjT5HGj2gDPds_j5PPlu9uLD-nV7P304vwq1bwgQ0qqSimqRQYa55WuMwo8TnhRMAUEmqIiLNdUFzonWOOiKXFDQRGimeB1IdhxMt16a6eWsvemU34jnTLy7oXzc6n8YHQLssKUq1zntMB5ltWkbAjUumJYENwAVdF1tnX1q6qLW7F9r9o96f6ONQs5d2tZEkGLjEXBq53Au28rCIPsTNDQtsqCWwVJRZ5hLHKOI_ryAbp0K2_jpxopRmnJcvKbmqvYgLGNi-fqUSrP83hvShguI3XyFyqOGjqjY6Sa-M_3C1782eivDu-zEwG6BbR3IXhopDbDXZCi2bSSYDkGVI4BlbuAxqI3D4ruvf_AX2_xhbG1-m7-T_8EUefv5Q
CitedBy_id crossref_primary_10_3389_fcell_2022_995462
crossref_primary_10_1016_j_placenta_2024_05_135
crossref_primary_10_1016_j_placenta_2024_09_018
crossref_primary_10_1038_s41598_025_94595_w
crossref_primary_10_3389_fcell_2024_1494072
crossref_primary_10_1016_j_cellsig_2024_111506
crossref_primary_10_1016_j_cophys_2023_100647
crossref_primary_10_1186_s13062_024_00526_6
crossref_primary_10_1016_j_placenta_2023_11_010
crossref_primary_10_1186_s12884_025_07424_3
crossref_primary_10_1186_s12958_024_01248_0
crossref_primary_10_3390_biomedicines11102681
Cites_doi 10.3892/mmr.2014.2214
10.1016/j.ajog.2017.11.568
10.1016/j.cbi.2013.11.010
10.1158/1078-0432.CCR-16-1025
10.1016/j.ejogrb.2013.05.005
10.1155/2014/103068
10.1016/j.ajog.2015.05.013
10.1080/10799893.2020.1870493
10.1158/0008-5472.CAN-07-6655
10.1007/s11906-017-0786-2
10.1007/s00011-019-01246-8
10.1016/j.arcmed.2014.10.003
10.1038/onc.2016.426
10.3892/ol.2018.7976
10.1161/HYPERTENSIONAHA.111.203489
10.1016/j.cell.2009.01.002
10.26355/eurrev_201909_19000
10.3892/mmr.2020.11050
10.3760/cma.j.cn112141-20200114-00039
10.1111/j.1365-2141.2011.08951.x
10.3892/ijo.2020.5057
10.1158/0008-5472.CAN-18-2545
10.1016/j.ajog.2010.01.057
10.1016/j.semcancer.2017.11.018
10.1016/j.freeradbiomed.2017.01.010
10.14670/HH-30.213
10.1097/MD.0000000000006509
10.1097/MIB.0000000000000009
10.1128/MCB.00410-18
10.1002/jcp.27291
10.1177/0960327120954252
10.1159/000505493
10.1055/s-0035-1570034
10.1038/nrg2540
10.1073/pnas.1607849113
10.1016/j.placenta.2012.07.012
10.1016/j.rbmo.2011.02.016
10.1016/j.gene.2018.01.049
ContentType Journal Article
Copyright Copyright © 2022 Xiaohua Luo et al.
COPYRIGHT 2022 John Wiley & Sons, Inc.
Copyright © 2022 Xiaohua Luo et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Xiaohua Luo et al. 2022
Copyright_xml – notice: Copyright © 2022 Xiaohua Luo et al.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: Copyright © 2022 Xiaohua Luo et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2022 Xiaohua Luo et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1155/2022/4250621
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic




MEDLINE
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: Proquest Central Journals
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1466-1861
Editor Lembo, Francesca
Editor_xml – sequence: 1
  givenname: Francesca
  surname: Lembo
  fullname: Lembo, Francesca
EndPage 20
ExternalDocumentID oai_doaj_org_article_b025a7c7280744d19f1edcb30610fe2a
PMC9162843
A706121309
35664920
10_1155_2022_4250621
Genre Journal Article
GeographicLocations Canada
China
United States--US
GeographicLocations_xml – name: China
– name: Canada
– name: United States--US
GrantInformation_xml – fundername: Key specialized research and development program in Henan province
  grantid: 212102310473
GroupedDBID ---
0R~
188
24P
29M
2WC
36B
4.4
53G
5GY
5VS
7X7
88E
8FE
8FH
8FI
8FJ
8G5
AAFWJ
AAJEY
ABDBF
ABUWG
ACCMX
ACGFO
ACIHN
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFPKN
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
LK8
M1P
M2O
M48
M7P
O5R
O5S
OK1
P2P
PGMZT
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RHU
RHW
RHX
RNS
RPM
SV3
TR2
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
OVT
PHGZM
2UF
CAG
CEFSP
CGR
CNMHZ
COF
CUY
CVF
ECM
EIF
EJD
IL9
IPNFZ
NPM
OVD
RIG
TEORI
UZ5
PMFND
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c581t-1bbaa2c64ec07bcd42e507b5883ae1ef8b137c2c8c710c08f90f2ea11c365d863
IEDL.DBID 7X7
ISSN 0962-9351
1466-1861
IngestDate Wed Aug 27 01:30:30 EDT 2025
Thu Aug 21 17:51:55 EDT 2025
Fri Jul 11 02:14:31 EDT 2025
Fri Jul 25 12:04:12 EDT 2025
Tue Jun 17 22:02:37 EDT 2025
Tue Jun 10 21:03:42 EDT 2025
Thu Apr 03 07:09:45 EDT 2025
Tue Jul 01 01:13:37 EDT 2025
Thu Apr 24 23:01:16 EDT 2025
Wed Apr 16 06:26:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Xiaohua Luo et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c581t-1bbaa2c64ec07bcd42e507b5883ae1ef8b137c2c8c710c08f90f2ea11c365d863
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Francesca Lembo
ORCID 0000-0003-2971-558X
OpenAccessLink https://www.proquest.com/docview/2673229371?pq-origsite=%requestingapplication%
PMID 35664920
PQID 2673229371
PQPubID 2037497
PageCount 20
ParticipantIDs doaj_primary_oai_doaj_org_article_b025a7c7280744d19f1edcb30610fe2a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9162843
proquest_miscellaneous_2674006750
proquest_journals_2673229371
gale_infotracmisc_A706121309
gale_infotracacademiconefile_A706121309
pubmed_primary_35664920
crossref_citationtrail_10_1155_2022_4250621
crossref_primary_10_1155_2022_4250621
hindawi_primary_10_1155_2022_4250621
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-26
PublicationDateYYYYMMDD 2022-05-26
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-26
  day: 26
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Mediators of inflammation
PublicationTitleAlternate Mediators Inflamm
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
– name: Wiley
References 22
23
24
25
26
27
28
29
F. Azizi (14) 2017; 6
30
31
10
32
11
33
12
34
13
35
36
15
37
16
38
B. Lamarca (4) 2010; 62
17
39
18
19
1
2
3
5
6
7
8
9
40
20
21
References_xml – ident: 17
  doi: 10.3892/mmr.2014.2214
– ident: 10
  doi: 10.1016/j.ajog.2017.11.568
– ident: 2
  doi: 10.1016/j.cbi.2013.11.010
– ident: 36
  doi: 10.1158/1078-0432.CCR-16-1025
– ident: 1
  doi: 10.1016/j.ejogrb.2013.05.005
– ident: 12
  doi: 10.1155/2014/103068
– ident: 29
  doi: 10.1016/j.ajog.2015.05.013
– ident: 40
  doi: 10.1080/10799893.2020.1870493
– ident: 33
  doi: 10.1158/0008-5472.CAN-07-6655
– ident: 5
  doi: 10.1007/s11906-017-0786-2
– ident: 11
  doi: 10.1007/s00011-019-01246-8
– ident: 3
  doi: 10.1016/j.arcmed.2014.10.003
– ident: 39
  doi: 10.1038/onc.2016.426
– ident: 20
  doi: 10.3892/ol.2018.7976
– ident: 8
  doi: 10.1161/HYPERTENSIONAHA.111.203489
– ident: 7
  doi: 10.1016/j.cell.2009.01.002
– ident: 21
  doi: 10.26355/eurrev_201909_19000
– ident: 35
  doi: 10.3892/mmr.2020.11050
– ident: 25
  doi: 10.3760/cma.j.cn112141-20200114-00039
– ident: 19
  doi: 10.1111/j.1365-2141.2011.08951.x
– ident: 26
  doi: 10.3892/ijo.2020.5057
– ident: 30
  doi: 10.1158/0008-5472.CAN-18-2545
– ident: 13
  doi: 10.1016/j.ajog.2010.01.057
– ident: 38
  doi: 10.1016/j.semcancer.2017.11.018
– ident: 28
  doi: 10.1016/j.freeradbiomed.2017.01.010
– volume: 62
  start-page: 105
  issue: 2
  year: 2010
  ident: 4
  article-title: The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia
  publication-title: Minerva Ginecologica
– ident: 34
  doi: 10.14670/HH-30.213
– ident: 15
  doi: 10.1097/MD.0000000000006509
– ident: 22
  doi: 10.1097/MIB.0000000000000009
– ident: 37
  doi: 10.1128/MCB.00410-18
– ident: 27
  doi: 10.1002/jcp.27291
– ident: 31
  doi: 10.1177/0960327120954252
– volume: 6
  start-page: 22
  issue: 1
  year: 2017
  ident: 14
  article-title: Evaluation of placental mir-155-5p and long non-coding RNA sONE expression in patients with severe pre-eclampsia
  publication-title: International Journal of Molecular and Cellular Medicine
– ident: 24
  doi: 10.1159/000505493
– ident: 6
  doi: 10.1055/s-0035-1570034
– ident: 32
  doi: 10.1038/nrg2540
– ident: 9
  doi: 10.1073/pnas.1607849113
– ident: 18
  doi: 10.1016/j.placenta.2012.07.012
– ident: 16
  doi: 10.1016/j.rbmo.2011.02.016
– ident: 23
  doi: 10.1016/j.gene.2018.01.049
SSID ssj0005448
Score 2.3961198
Snippet Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Analysis
Animals
Apoptosis
Arginine
B cells
Cell adhesion & migration
Cell culture
Cell growth
Cell Line, Tumor
Cell Movement - genetics
Cell proliferation
Cell Proliferation - genetics
Cholecystokinin
Cytokines
DNA methylation
Enzyme-linked immunosorbent assay
Female
Forkhead Box Protein O3 - genetics
Forkhead Box Protein O3 - metabolism
FOXO3 protein
Gelatinase A
Gene expression
Humans
Immune response
Inflammation
Inflammation - metabolism
Methylation
MicroRNAs - genetics
MicroRNAs - metabolism
miRNA
NG-Nitroarginine methyl ester
Oxidative stress
Pathogenesis
Peripheral blood
Placenta
Placenta - metabolism
Pre-eclampsia
Pre-Eclampsia - metabolism
Preeclampsia
Pregnancy
Rats
Reverse transcription
Transfection
Trophoblasts - metabolism
Womens health
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yoPgifltvlQgnPki55rPp4ykup7Ce6J3sW0nSlCtoe-zunQj-8c6k7bIV5V58bDO06cwk8xs6-Q0hB1wIp63lKQvWpjJomxa2ZqmoTWWKvDAyHqRdfNTHZ_LDUi13Wn1hTVhPD9wr7tBBULa5zyNri6xYUbNQeQdIl2V14BEaQcwbk6mxuAOyjrHMXSnM8PkheGemOZsEoMjTv92Nb55jHvyj-Rva_LNocicKze-SOwN8pEf9tO-RG6G9T24thh_kD8ivRQDN9_VtdBHbcISKfmnwaBEEKdrV9HvzOYXZUuznGZnD1xRAIN2pHkKpT6sQPHjLxbqx9H1LvzabVUdtW_UXVx11P-lpLCPH585PlifiITmbvzt9e5wODRZSrwzbpMw5MJPXMvgsd76SPAA8dMoYYQMLtXFM5J574wGH-MzURVbzYBnzQqvKaPGI7LVdG54QKhXyzDgvtRcyqzLnmNd1LkCq8ABJEvJ61HrpB_ZxbILxrYxZiFIl2qgcbJSQl1vpi5514x9yb9CAWxnkyo43wIPKwYPK6zwoIa_Q_CWuaJiSt8PBBPgw5MYqj3KEgRDri4TMJpKwEv1k-GBwoGsmPRu9qxw2jHXJdQ5bK5ITJuTFdhhfgEVwbeguo4xEdKFAm497Z9y-SAAslwWHkXziphPVTEfa5jzSiUOCABhFPP0futwnt_FTsbyC6xnZ26wuwzNAbRv3PC7Q34pZOx4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA96oPgifltdJcKJD1JsPpqmj6e4rMJ6oneybyFJU66g7bG7pwj-8c6k3Xo9FX1sM23TzCTzGzL5DSH7XAinrOUpC9amMiiblrZmqah1pcui1DIepF2-U4tj-XaVrwaSpM3vW_jg7TA85y_AtDKFB8Yvg4FhUL5Y_crkkLFIFoBxnpYiZ7v89gvPTjxPJOgfl-ErJxgAf2v-BDMvZkuecz_zG-T6gBvpQa_om-RSaG-Rq8thZ_w2-bEMMOR9YhtdxvoboaIfGzxTBN6JdjX90nxIobcUC3lGyvANBfRHz6UNodT7dQgezOR001j6pqWfmu26o7at-ouvHXXf6VHMH8f3zg9Xh-IOOZ6_Pnq1SIfKCqnPNdumzDnQj1cy-KxwvpI8AC50udbCBhZq7ZgoPPfaAwDxma7LrObBMuaFyiutxF2y13ZtuE-ozJFgxnmpvJBZlTnHvKoLAVKlByySkOe7UTd-oB3H6hefTQw_8tygjsygo4Q8HaVPe7qNv8i9RAWOMkiSHW-A4ZhhzhkHeM4WvoiEP7JiZc1Aiw6CJJbVgduEPEP1G5zK0CVvhxMJ8GNIimUOCsR_4OTLhMwmkjAF_aR5fzCgf3R6trMuM6wUG8NVAWsqshIm5MnYjB_A7Lc2dGdRRiKsyGE07_XGOH5IAB6XJYeWYmKmk6GZtrTNSeQRh8gAwIl48H-9f0iu4SVmTnA1I3vb9Vl4BIBs6x7H6fgTqXMqMA
  priority: 102
  providerName: Hindawi Publishing
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELaqIhAXxLuhCzJSEQcUiJ9JDggVxKogLUXQRXuLbMehkUrS7m6BSvx4Zpzs0lQFjoknie2Zsb9Rxt8QssOFsNoYHjNvTCy9NnFuKhaLKiuzPM0zGQ7STj7oval8P1OzDbKqNtpP4OLS0A7rSU3nR89_npy9Aod_GRxeKYzf-QuwvUTjifIrsCelWMtgIv_whisZ6mgBXudxLhRbpcBfeHqwOQUO__VKffUQY-Qf9WVI9GJC5bkdanyT3OihJd3tbOEW2fDNbXJt0v88v0N-TTxopct9o5NQosOX9HONx45gA6NtRb_Vn2LoLcVan4FVfEEBINJzmUUo9XHuvQNLOl7Uhr5r6Jd6OW-pacru4ntL7Rk9CCnm-N7x_mxf3CXT8duDN3txX3whdipjy5hZCyp0WnqXpNaVknuAjlZlmTCe-SqzTKSOu8wBRnFJVuVJxb1hzAmtykyLe2SzaRu_RahUyEFjndROyKRMrGVOV6kAqdwBXInIs9WsF65nJscCGUdFiFCUKlBHRa-jiDxZSx93jBx_kXuNClzLII92uNHOvxa9WxYWIJ9JXRo4gWTJ8oqBFi3EUSypPDcReYrqL9D-oEvO9IcWYGDIm1XspggRAQfkERkNJMFL3aB5pzeg_3R6tLKuYuULBdcpLLtIXBiRx-tm_AAmyDW-PQ0yEpGHgtm83xnj-kMCILvMObSkAzMdTM2wpakPA9U4BA-AX8SDf3drm1zHQWBSBdcjsrmcn_qHgNWW9lFww98sZDY-
  priority: 102
  providerName: Scholars Portal
Title Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3
URI https://dx.doi.org/10.1155/2022/4250621
https://www.ncbi.nlm.nih.gov/pubmed/35664920
https://www.proquest.com/docview/2673229371
https://www.proquest.com/docview/2674006750
https://pubmed.ncbi.nlm.nih.gov/PMC9162843
https://doaj.org/article/b025a7c7280744d19f1edcb30610fe2a
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLZgE4gXxJ1CqYw0xAOKFt9yeUIbrOpA3aayob5FtuOwSJCUtgMh8eM5x3W7BXF5iZT6qHF8PtufnePvELLDhTCJ1jxiTutIukRHua5YJKqszPI0z6Q_SDs-SkZn8t1UTcOG2yKEVa7HRD9Ql63FPfJdnqSAPVRvez37GmHWKPy6GlJoXCfbKF2GqE6n6WWIh_TZs4Cl8ygXiq0D35XCNT_fBbzGCWedKckr92_G5xvnuDL-Xv-Jf_4eRnllXhreIbcDoaR7KwTcJddcc4_cHIdP5vfJz7EDX6wi3ujYJ-ZwJf1Q42EjmLZoW9Ev9SSC2lLM8Om1xBcUaCG9Ek-EVidz5yzgZ7aoNT1s6Md6OW-pbsrVzbeWmh_01AeW4_8Oj6fH4gE5Gx6cvhlFIeVCZFXGlhEzBhxnE-lsnBpbSu6AMBqVZUI75qrMMJFabjMLzMTGWZXHFXeaMSsSVWaJeEi2mrZxjwmVCpVnjJWJFTIuY2OYTapUgFVugaT0yKt1qxc26JFjWozPhV-XKFWgj4rgox55sbGerXQ4_mK3jw7c2KB6tv-hnX8qQmcsDBA9ndrUKwHJkuUVAy8aWD2xuHJc98hLdH-BfRyqZHU4qgAvhmpZxV6KxBBm_7xH-h1L6Ju2U7wTAPSfSvfX6CrCELIoLgHfI883xfgADItrXHvhbSTyDQWt-WgFxs2DBBB1mXMoSTsw7TRNt6Spz73AOCwZgLWIJ_-u1lNyC18CQyl40idby_mFewYMbWkGvhsOyPb-wdHJBO7eHr4f-N0OuI5lBtfJaPoLS6I6BA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEccL4mZhASO14gFFjY9cDwiVY7VLuy2CLdq3YDsOjQTJsrulqsRv4jcy4yTbBnE89THxKJl4xjPfOOMZQja4EDpUinvMKuVJGyovUTnzRB5ncRIlsXQHacd74fBAvp0G0zXysz0Lg2mVrU10hjqrDO6Rb_EwAt3D6m0vZt887BqFf1fbFhq1WuzYk2MI2RbPR69BvpucD95MXg29pquAZ4KYLT2mNfBmQmmNH2mTSW4BE-kgjoWyzOaxZiIy3MQGnK_x4zzxc24VY0aEQRaHAp57gVwEx-tjsBdNo9OUEum6dUFUwL1EBKxNtA8C3GPgW7A-_JCzjgt0nQJW_uDSIUbix8Wf8O7vaZtn_ODgOrnWAFi6XWvcDbJmy5vk8rj5RX-L_BhbkH2dYUfHrhGIzeiHAg83gZukVU6_Fu894JZiR1FXu3xBAYbSM_lLSPVubq0BfZ0tCkVHJf1YLOcVVWVWX3yvqD6hE5fIjs8d7E_3xW1ycC7CuEPWy6q09wiVAVa60UaGRkg_87VmJswjAVSJAVDUI8_aWU9NU_8c23B8SV0cFAQpyihtZNQjmyvqWV334y90L1GAKxqs1u1uVPPPabP4Uw3AUkUmcpWHZMaSnIEUNURrzM8tVz3yFMWfok0BloxqjkbAh2F1rnQ7QiAKaCPpkX6HEmyB6QxvNAr0H6b7rXaljclapKcLrEeerIbxBZiGV9rqyNFIxDcBzObdWhlXLxIQGMiEw0jUUdPO1HRHyuLQFTSHEAVQkrj_b7YekyvDyXg33R3t7TwgV_GDMI2Dh32yvpwf2YeADpf6kVuSlHw6bxvwC5ZjciQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVFRcEG8CBRapFQdkxfvw64BQSxs1lKRRaavczO56TS2BHZKUqhK_jF_HjB9pjXicekx2ZK93Zme-sb-dIWSDC6F9pbjDrFKOtL5yIpUyR6RhEkZBFMryIO1w5O8dy_cTb7JCfjZnYZBW2fjE0lEnhcF35D3uB2B7WL2tl9a0iPFO_-30m4MdpPBLa9NOozKRfXtxDunb_M1gB3S9yXl_9-jdnlN3GHCMF7KFw7SGeRpfWuMG2iSSW8BH2gtDoSyzaaiZCAw3oYFAbNwwjdyUW8WYEb6XhL6A694gqwFmRR2yur07Gh9eEkxk2bsLcgTuRMJjDe3e8_CNA-_BbnF9zloBsewbsIwON08xLz_P_oR-fydxXomK_Tvkdg1n6VZlf3fJis3vkbVh_cH-PvkxtGAJFd-ODsu2IDahHzM86gRBkxYp_ZodOjBbiv1Fy0rmcwqglF5hM6HUeGatAeudzjNFBzk9yRazgqo8qX58L6i-oEclrR2v2z-YHIgH5Pha1PGQdPIit48JlR7WvdFG-kZIN3G1ZsZPAwFSkQGI1CWvm1WPTV0NHZtyfInLrMjzYtRRXOuoSzaX0tOqCshf5LZRgUsZrN1d_lHMPse1K4g1wEwVmKCsQyQTFqUMtKghd2Nuarnqkleo_hg9DEzJqPqgBDwY1uqKtwKEpYA9oi5Zb0mCZzCt4Y3agP4z6fXGuuLagc3jy-3WJS-Xw3gDJOXltjgrZSSiHQ9W81FljMsbCUgTZMRhJGiZaWtp2iN5dlqWN4eEBTCTePLvab0ga7D_4w-D0f5TcgufBzkd3F8nncXszD4DqLjQz-s9Scmn63YDvwCDyXe_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methylation+Mediated+Silencing+of+miR-155+Suppresses+the+Development+of+Preeclampsia+In+Vitro+and+In+Vivo+by+Targeting+FOXO3&rft.jtitle=Mediators+of+inflammation&rft.au=Luo%2C+Xiaohua&rft.au=Pan%2C+Ci&rft.au=Guo%2C+Xiaopei&rft.au=Gu%2C+Cunhua&rft.date=2022-05-26&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0962-9351&rft.eissn=1466-1861&rft.volume=2022&rft_id=info:doi/10.1155%2F2022%2F4250621&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon